Results 81 to 90 of about 90,748 (118)

Toxicity study of SARS-CoV-2 Spike protein expressed on Bacillus subtilis spores. [PDF]

BMC Microbiol
Hazan A, Saperi AA, Zulkifli N, Rahim NM, Tiong V, Lee HY, AbuBakar S.   +6 more
europepmc   +1 more source

Sex differences in vaccine-induced immunity in mice immunized with integrase-defective lentiviral vector delivering the SARS-CoV-2 Spike protein. [PDF]

Front Immunol
Farina I, Gallinaro A, Borghi M, Pirillo MF, Falce C, Canitano A, Michelini Z, Zappitelli A, Di Virgilio A, Picozza M, Cara A, Negri D.   +11 more
europepmc   +1 more source

The sequence and structural integrity of the SARS-CoV-2 Spike protein transmembrane domain is crucial for viral entry. [PDF]

Commun Biol
Ortiz-Mateu J, Belda D, Avilés-Alía AI, Alonso-Romero J, García-Murria MJ, Mingarro I, Geller R, Martinez-Gil L.   +7 more
europepmc   +1 more source

SARS-CoV-2 spike protein-induced inflammation underlies proarrhythmia in COVID-19. [PDF]

Sci Rep
Mezache L, Soltisz A, Tili E, Nuovo GJ, Veeraraghavan R.   +4 more
europepmc   +1 more source

Structural and Functional Impacts of SARS-CoV-2 Spike Protein Mutations: Insights From Predictive Modeling and Analytics. [PDF]

JMIR Bioinform Biotechnol
Netsey EK, Naandam SM, Asante Jnr J, Abraham KE, Yadem AC, Owusu G, Shaffer JG, Srivastav SK, Doumbia S, Owusu-Dabo E, Morkle CE, Yemeh D, Manortey S, Yankson E, Sangare M, Kakraba S.   +15 more
europepmc   +1 more source

Endothelial Cell Activation by SARS-CoV-2 Spike Protein and Its RBD: Central Player of the Immunothrobotic Response in COVID-19. [PDF]

Curr Issues Mol Biol
Cano-Mendez A, Garcia-Larragoiti N, Ambriz-Murillo Y, Velez-Chavez J, Vega-Agavo R, Vazquez-Marrufo G, Higareda-Mendoza AE, Ochoa-Zarzosa A, Viveros-Sandoval ME.   +8 more
europepmc   +1 more source

HU308, A Selective Cannabinoid Type-2 Receptor Agonist, Mitigates SARS-CoV-2 Spike Protein-Induced Acute Lung Injury in Mice. [PDF]

Lung
Lockett J, Nicholson G, Richards N, Washington R, Nagre N.   +4 more
europepmc   +1 more source

SARS-CoV-2 Spike Protein as a Target of the COVID-19 Vaccine Disrupts Insulin Signaling in Type 2 Diabetes. [PDF]

MedComm (2020)
Zhai L, Zhuang M, Wong HK, Lin C, Ying H, Zhang J, Bao G, Zhang Y, Xu S, Luo J, Yuan S, Wong HLX, Bian ZX.   +12 more
europepmc   +1 more source

Tissue tropism and functional adaptation of the SARS-CoV-2 spike protein in a fatal case of COVID-19. [PDF]

J Virol
Johnson KEE, Stein S, Boateng RA, Jain S, Ramelli SC, Stantliff T, Curran S, Ramos-Benítez MJ, Platt AP, Banakis S, Wang W, Hewitt SM, Zerbe C, Holland SM, Kang EM, Singh M, de Wit E, Lauer WA, Rouchka EC, Smith M, Suthar MS, Chertow DS, Ghedin E.   +22 more
europepmc   +1 more source